Batimastat
SIGMA/SML0041 - ≥98% (HPLC)
Synonym: BB-94; (2R,3S)
CAS Number: 130370-60-4
Empirical Formula (Hill Notation): C23H31N3O4S2
Molecular Weight: 477.64
MDL Number: MFCD00866533
Linear Formula: C23H31N3O4S2
Product Type: Chemical
| assay | ≥98% (HPLC) |
| color | white to tan |
| form | powder |
| InChI | 1S/C23H31N3O4S2/c1-15(2)1 |
| InChI key | XFILPEOLDIKJHX-QYZOEREBSA |
| Quality Level | 100 ![]() |
| shipped in | wet ice |
| SMILES string | CNC(=O)[C@H](Cc1ccccc1)NC |
| solubility | DMSO: ≥15 mg/mL |
| storage temp. | −20°C |
| Application: | Batimastat has been used to inhibit matrix metalloproteinases (MMPs) activity in various studies. |
| Biochem/physiol Actions: | Batimastat is a potent, broad spectrum matrix metalloprotease (MMP) inhibitor. |
| Biochem/physiol Actions: | Batimastat is hydroxamate-type inhibitor of matrix metalloproteinases (MMP). It inhibits the growth and spread of lung tumors, breast cancer regrowth and human colon tumor growth and spread in mouse models. Batimastat reduces MMP-mediated vascular dysfunction and vessel wall damage and enhances the sealing ability and bond strength of dental adhesives. |
| Packaging: | 5, 25 mg in glass bottle |
| RIDADR | NONH for all modes of transport |
| WGK Germany | WGK 3 |
| Flash Point(F) | Not applicable |
| Flash Point(C) | Not applicable |
| Purity | ≥98% (HPLC) |
| Storage Temp. | −20°C |
| UNSPSC | 12352200 |

